NCT03098836 Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT03098823 A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE Status COMPLETED Phase PHASE4
NCT03093272 A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer Status TERMINATED Phase PHASE2
NCT03036904 Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas Status COMPLETED Phase PHASE1
NCT03023891 Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids Status COMPLETED Phase PHASE1
NCT03023358 Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients Status UNKNOWN Phase PHASE3
NCT03023046 Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Status COMPLETED Phase PHASE2
NCT03016741 Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT03012321 Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03009981 A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer Status COMPLETED Phase PHASE3
NCT03007732 Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT Status COMPLETED Phase PHASE2
NCT03003520 A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE2
NCT02994927 A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis Status COMPLETED Phase PHASE3
NCT02990403 The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss Status UNKNOWN Phase PHASE4
NCT02987244 Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma Status UNKNOWN Phase PHASE1/PHASE2
NCT02985957 A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650) Status COMPLETED Phase PHASE2
NCT02961257 Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a Docetaxel Status COMPLETED Phase PHASE3
NCT02960022 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study Status RECRUITING Phase PHASE2